May 11, 2020 / 11:44 AM / 18 days ago

BRIEF-Moleculin Provides Additional Comments Regarding Trading Halt

Moleculin Biotech Inc:

* MOLECULIN PROVIDES ADDITIONAL COMMENTS REGARDING TRADING HALT

* MOLECULIN BIOTECH - SINCE TEMPORARY SUSPENSION BY SEC, ADDITIONAL DATA HAS COME TO CO’S ATTENTION REGARDING CLAIMS DISSEMINATED BY THIRD PARTIES

* MOLECULIN BIOTECH - LEARNED THAT SOME THIRD PARTIES MADE CLAIMS & DISTRIBUTED INFORMATION DURING PERIOD BETWEEN MARCH 20 TO MAY 5

* MOLECULIN BIOTECH - LEARNED THAT THIRD PARTIES MADE CLAIMS ABOUT POTENTIAL EFFICACY & CLINICAL DEVELOPMENT OF WP1122 WITH RESPECT TO CORONAVIRUS

* MOLECULIN BIOTECH - SEC’S SUSPENSION OF TRADING MOLECULIN STOCK IS SCHEDULED TO TERMINATE AT 11:59 P.M. ET ON MAY 15 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below